Skip to content
← All startups
JURA Bio logo

JURA Bio

Series B

Developer of cell therapies for immunological disorders. It offers a machine learning-guided RedPoint Design System for drug discovery that combines transformative MHC-CAR and cell-free systems for the development of autoimmune therapeutics.

Life Sciences · Cell Therapy · Boston, United States · EST 2017

About

Developer of cell therapies for immunological disorders. It offers a machine learning-guided RedPoint Design System for drug discovery that combines transformative MHC-CAR and cell-free systems for the development of autoimmune therapeutics.

Institutional investors

Fontus CapitalMassachusetts Life Sciences Center

Latest coverage

📰 Browse funding news — rounds, valuations, and market moves for founders.

Investor directory

🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.

Raising like JURA Bio?

Analyze your pitch deck before your next raise.

Analyze My Deck →